Recent Updates
Recently added Catalysts
TLSA

June 2020 Tiziana Life Science plc Appointment of Broker Tiziana Life Sciences plc (AIM:TILS) is pleased to announce the appointment of Optiva Securities Limited as its broker with immediate effec

Monday, June 1, 2020 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Life Sciences plc (AIM:TILS) is pleased to announce the appointment of Optiva Securities Limited as its broker with immediate Gabriele Cerrone, Chairman and founder +44 (0)20 7495 2379 Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner + 44 (0)20 7213 0883

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.9%
average across 8 past catalysts
Lead asset
Foralumab
Phase 2 · Secondary Progressive Multiple Sclerosis

Full Press Release Details

Life Sciences plc (AIM:TILS) is pleased to announce the appointment of Optiva Securities Limited as its broker with immediate
Gabriele Cerrone, Chairman and founder +44 (0)20 7495 2379
Cairn Financial Advisers LLP (Nominated adviser)
Liam Murray / Jo Turner + 44 (0)20 7213 0883
Optiva Securities Limited
Robert Emmet + 44 (0)20 3981 4173
further information, please visit the Company's website at www.tizianalifesciences.com.
ShareAdd on Google
Tags: TLSA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jun 1, 2020

Biotech snapshot

Lead asset
ForalumabPhase 2
Secondary Progressive Multiple Sclerosis →

Catalyst track record

+23%
best trade around TLSA's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for TLSA.

See every catalyst's timing & PoA →